Sentences with phrase «cancer research technology»

«This clinical trial simply would not have been possible without the CDP initiative and it demonstrates how Cancer Research UK and Cancer Research Technology can work with industry to develop anti-cancer drugs that would otherwise remain on companies» shelves.

Cancer Research Technology can receive downstream royalties and development milestones from licensed programs.

CDP is a joint initiative between Cancer Research UK's Drug Development Office and Cancer Research Technology, to progress promising anti-cancer agents which pharmaceutical companies do not have the resources to progress through early phase clinical trials.

Cancer Research Technology will lead drug discovery R&D activity and can progress clinical candidates through phase one trials.

Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached an agreement with AstraZeneca to take compound AZD - 3965 — a first - of - its - kind experimental drug to potentially treat a range of cancers - into clinical trial.

Cancer Research UK's commercial activity operates through Cancer Research Technology Ltd. (CRT), a wholly owned subsidiary of Cancer Research UK.

If it chooses not to, the rights will be given to Cancer Research Technology to secure an alternative partner and ensure the drug has every possible chance of reaching patients.

Clinical Development Partnerships (CDP) is a joint initiative between Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm.

Dr Iain Foulkes, Cancer Research Technology's CEO, said: «This bold and exciting collaboration between one of industry's leading innovators, Celgene, and CRT is part of our theme - based drug discovery approach and helps leverage our understanding of cancer biology and the needs of patients to drive the most promising discoveries into the clinic.

Dr Ian Walker, licensing manager for clinical partnerships at Cancer Research Technology, said: «It is fantastic to see a drug from our CDP programme progressing toward a clinical trial to be tested as a potential new treatment for cancer patients.

This is a new collaborative venture between Leukemia & Lymphoma Research, Cancer Research UK and its development and commercialisation arm Cancer Research Technology, aimed at accelerating the delivery of promising new treatments into blood cancers.

She is currently working as an analyst for a medical technology consulting firm and will shortly take a position as a marketing assistant for Cancer Research Technology — the technology transfer section of the funding organisation Cancer Research UK.

Cancer Research UK owns a specialist technology - transfer company called Cancer Research Technology Ltd (CRT) that encourages start - up companies to get partnered products onto the market.

His case was assigned to his friend Blundy, then a technology transfer manager at Cancer Research Technology, who was charged with helping him create a commercial spinoff.

Not exact matches

But the 23rd annual Sohn Investment Conference — held in memory of Ira Sohn, and benefiting pediatric cancer research and treatment — had a larger - than - usual contingent of technology investors, and not everyone agreed with Gundlach's stance.

He sought out the rights to the technology and teamed with the Princess Margaret Cancer Centre in Toronto to conduct research.

PERTH - based Medi - tech Research Limited may be on the brink of a major advance in cancer therapy with its hyaluronic acid technology for the delivery of anti-cancer drugs.

FACIT also facilitates technology transfer, partnerships, and collaborations with the Ontario Institute for Cancer Research >

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

We witness the marvels of technology which have been made possible through the advances of science, and we wait hopefully for the results of continuing research, for example in the cancer field.

Jiachen Lee, Arooba Ahmed and Jillian Parker, a trio of young scientists from the Half Hollow Hills school district won the $ 100,000 top team award in the prestigious Siemens Competition in Math, Science & Technology for their research into cell division that could help find treatments to cancers, viruses and other diseases.

Science and Technology — Subject: Clinical trials Witness (es): Professor Karol Sikora, Medical Director of Cancer Partners UK and Dean, University of Buckingham Medical School and Simon Denegri, NIHR National Director for Public Participation and Engagement in Research and Chair, INVOLVE; Tracey Brown, Managing Director, Sense About Science and Dr Helen Jamison, Deputy Director, Science Media Centre; Sir Kent Woods, Chief Executive,, Dr Janet Wisely, Chief Executive, Health Research Authority, Bill Davidson, Acting Deputy Director and Head of Research Standards and Support, Department of Health and Peter Knight, Deputy Director, Head of Research Information and Intelligence, Department of Health Location: Room 8, Palace of Westminster

Over $ 30 million was added for cancer and Gulf War Illness research, and other amendments increased funding for military munitions research, medical technology, and the Navy's electromagnetic railgun project.

The technology may one day lead to new imaging instruments and microscopes for use in medicine and scientific research, such as devices for detecting early signs of skin cancer or early visual cues for food spoilage.

For this study, Yanik's team developed a new technology to inject RNA carried by nanoparticles called lipidoids, previously designed by Daniel Anderson, an associate professor of chemical engineering, member of the Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and an author of the new paper.

In 1998, Kouzarides approached the technology arm of his major funding source, the charity Cancer Research UK, about developing medical treatments from his work.

«Its complexity has scared away many cancer scientists,» notes Robert Weinberg, a researcher at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research.

«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight cancer.»

«Everyone is working on these [drugs] like crazy,» says David Lane, a cancer biologist at the Agency for Science, Technology and Research in Singapore, and a co-discoverer of p53.

Susan Hockfield is well known for her role in launching the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology and the MIT Energy Initiative, while she served as the research university's first female and first biologist prResearch at the Massachusetts Institute of Technology and the MIT Energy Initiative, while she served as the research university's first female and first biologist prresearch university's first female and first biologist president.

«It was a predictable outcome for those of us who believe in the technology already» says Mark Schiffman, who leads research into HPV at the National Cancer Institute in Washington DC.

A major focus of my research is on developing new technologies, based on hypothesis - driven, targeted mass spectrometry, for relieving this bottleneck to testing potential new blood - based diagnostics for detection of cancer.

• Monday on ScienceInsider, Eliot Marshall wrote about a $ 540 million gift from the Daniel K. Ludwig Trust to Ludwig cancer centers at six research institutions: «Harvard Medical School in Boston; Johns Hopkins University in Baltimore, Maryland; the Massachusetts Institute of Technology in Cambridge; the Memorial Sloan - Kettering Cancer Center in New York City; Stanford University in Palo Alto; and the University of Chicago.&cancer centers at six research institutions: «Harvard Medical School in Boston; Johns Hopkins University in Baltimore, Maryland; the Massachusetts Institute of Technology in Cambridge; the Memorial Sloan - Kettering Cancer Center in New York City; Stanford University in Palo Alto; and the University of Chicago.&Cancer Center in New York City; Stanford University in Palo Alto; and the University of Chicago.»

It is «not large research consortia, not new technologies, not cancer centers,» Weinberg said, but the young individual investigator.

Howard Hughes Medical Institute, Department of Biology, McGovern Institute for Brain Research, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

In turn, Parsaghian of Peregrine Pharmaceuticals predicts that antibody - based therapeutics — and diagnostics — will continue to be a growth area in cancer research, together with other protein - based biological agents and stem cell technology.

Cancer research has moved with the times, embracing new technologies enabling scientists to pursue more varied research goals than ever.

«The connection between inflammation and cancer has moved to center stage in the research arena,» notes Robert A. Weinberg of the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, who has highlighted the changing emphasis in a revision of his leading textbook, The Biology of Cancer (Garland Science, cancer has moved to center stage in the research arena,» notes Robert A. Weinberg of the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, who has highlighted the changing emphasis in a revision of his leading textbook, The Biology of Cancer (Garland Scienceresearch arena,» notes Robert A. Weinberg of the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, who has highlighted the changing emphasis in a revision of his leading textbook, The Biology of Cancer (Garland ScienceResearch, who has highlighted the changing emphasis in a revision of his leading textbook, The Biology of Cancer (Garland Science, Cancer (Garland Science, 2006).

He repeated a campaign promise to continue a doubling of the budgets of the Department of Energy's Office of Science, the National Institute of Standards and Technology, and the National Science Foundation and to double spending on cancer research at the National Institutes of Health.

Instead, when she learned about the AAAS Science and Technology Policy Fellowships, she realized her background in cancer research could be put to use in another direction.

During my tenure at NCI, I redirected my research into expression genomics, an amalgam of cancer cell biology and comprehensive and massively parallel genetic technologies.

Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer.

His research interests include the molecular underpinnings of cervical cancer (including developing genetic screens), the identification of the genetic determinants of quantitative traits in humans, and the application of massively parallel sequencing technology for understanding the genetics of complex disease.

The tech transfer internship program at the University of Michigan is run by Elaine Brock, the director of the Medical School's Office of Technology Transfer and Corporate Research, a lawyer who was also trained in health services administration; and assistant director Maria Sippola - Thiele, a former National Cancer Institute postdoc who subsequently got her M.B.A. from the University of Michigan.

Now, a research team led by the Georgia Institute of Technology has developed a new treatment to thwart it by, in a sense, breaking cancer cells» legs.

This work was carried out with funding from the Association for International Cancer Research (United Kingdom), the Lymphoma Research Foundation (USA) and the Instituto de Salud Carlos III (Spain), and illustrates how new genome sequencing technologies are revolutionizing the study of different types of cCancer Research (United Kingdom), the Lymphoma Research Foundation (USA) and the Instituto de Salud Carlos III (Spain), and illustrates how new genome sequencing technologies are revolutionizing the study of different types of cancercancer.

Obama, he said, elevated the role of science and technology advisers throughout the executive branch, put in place plans to mitigate and prepare the United States for the impacts of climate change, set up health research initiatives to tackle such priorities as cancer and brain research, worked with international partners on scientific issues and used the White House as a platform from which to herald science and education, particularly for children.

The authors of the piece are Martha E. Pollack, president, Cornell University; Vincent Price, president, Duke University; Gary Gilliland, president, the Fred Hutchinson Cancer Research Center; Ronald J. Daniels, president, the Johns Hopkins University; L. Rafael Reif, president, the Massachusetts Institute of Technology; Samuel Hawgood, chancellor, the University of California, San Francisco; Freeman A. Hrabowski, president, the University of Maryland, Baltimore County; Mark S. Schlissel, president, the University of Michigan, Ann Arbor; Amy Gutmann, president, the University of Pennsylvania; and Rebecca Blank, chancellor, the University of Wisconsin - Madison.

Another student who was using phage - display technology to identify new molecular markers in ovarian cancer attended a clinic in gynecologic oncology once a week throughout her dissertation research.

His current research activities include the implementation of next generation sequencing technologies in a diagnostic setting and the use of this technology to better understand cancer etiology and treatment.